CGH
KRYS icon

Crossmark Global Holdings’s Krystal Biotech KRYS Stock Holding History

Crossmark Global Holdings’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$812K Sell
2,186
-108
-5% -$32.3K 0.01% 699
2026
Q1 		$593K Buy
2,294
+170
+8% +$45.2K 0.01% 775
2025
Q4 		$524K Buy
2,124
+55
+3% +$11.6K 0.01% 814
2025
Q3 		$365K Sell
2,069
-388
-16% -$58.1K 0.01% 1024
2025
Q2 		$338K Buy
2,457
+87
+4% +$12.8K 0.01% 1049
2025
Q1 		$427K Buy
2,370
+63
+3% +$10.6K 0.01% 929
2024
Q4 		$362K Buy
2,307
+121
+6% +$21.5K 0.01% 972
2024
Q3 		$398K Buy
2,186
+449
+26% +$86.6K 0.01% 962
2024
Q2 		$319K Buy
+1,737
New +$292K 0.01% 1040

Other funds holding KRYS

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Crossmark Global Holdings's KRYS Position: Q2 2026 in Review

Crossmark Global Holdings reduced its Krystal Biotech (KRYS) stake by 4.7% in Q2 2026, selling an estimated $32.3K and leaving 2,186 shares worth $812K. The position accounts for 0.01% of the portfolio, ranked #699.

Crossmark Global Holdings first reported a position in KRYS in Q2 2024 and has held it in 9 quarters since. 65 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Crossmark Global Holdings held 2,186 shares of Krystal Biotech worth $812K as of Q2 2026.
  • Crossmark Global Holdings sold 108 Krystal Biotech shares in Q2 2026, an estimated $32.3K.
  • Krystal Biotech made up 0.01% of Crossmark Global Holdings's portfolio in Q2 2026, its #699 holding.
  • Crossmark Global Holdings first reported a position in Krystal Biotech in Q2 2024 and has held it in 9 quarters since.
  • 65 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.